<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="sciences : Microbiology : Medical microbiology : Microbial pathogens :" exact="Viral" post="pathogens : Orthomyxoviruses : Influenza viruses : Influenza A"/>
 <result pre="Pathology and laboratory medicine : Pathogens : Microbial pathogens :" exact="Viral" post="pathogens : Orthomyxoviruses : Influenza viruses : Influenza A"/>
 <result pre=": Biology and life sciences : Organisms : Viruses :" exact="Viral" post="pathogens : Orthomyxoviruses : Influenza viruses : Influenza A"/>
 <result pre="sciences : Microbiology : Medical microbiology : Microbial pathogens :" exact="Viral" post="pathogens : Orthomyxoviruses : Influenza viruses : Influenza A"/>
 <result pre="Pathology and laboratory medicine : Pathogens : Microbial pathogens :" exact="Viral" post="pathogens : Orthomyxoviruses : Influenza viruses : Influenza A"/>
 <result pre=": Biology and life sciences : Organisms : Viruses :" exact="Viral" post="pathogens : Orthomyxoviruses : Influenza viruses : Influenza A"/>
 <result pre="Influenza A virus: H5N1 : Medicine and Health Sciences :" exact="Infectious" post="Diseases : Zoonoses: H5N1 : Biology and Life Sciences"/>
 <result pre="A virus: H5N1 : Medicine and Health Sciences : Infectious" exact="Diseases" post=": Zoonoses: H5N1 : Biology and Life Sciences :"/>
 <result pre="Life Sciences : Microbiology : Medical Microbiology : Microbial Pathogens:" exact="Viral" post="Pathogens : Medicine and Health Sciences : Pathology and"/>
 <result pre=": Pathology and Laboratory Medicine : Pathogens : Microbial Pathogens:" exact="Viral" post="Pathogens : Biology and Life Sciences : Organisms :"/>
 <result pre="Pathogens : Biology and Life Sciences : Organisms : Viruses:" exact="Viral" post="Pathogens : Biology and life sciences : Organisms :"/>
 <result pre="Sciences : Microbiology : Medical Microbiology : Microbial Pathogens :" exact="Viral" post="Pathogens : Paramyxoviruses: Sendai Virus : Medicine and Health"/>
 <result pre="Pathology and Laboratory Medicine : Pathogens : Microbial Pathogens :" exact="Viral" post="Pathogens : Paramyxoviruses: Sendai Virus : Biology and Life"/>
 <result pre=": Biology and Life Sciences : Organisms : Viruses :" exact="Viral" post="Pathogens : Paramyxoviruses: Sendai Virus : Biology and life"/>
 <result pre="sciences : Microbiology : Medical microbiology : Microbial pathogens :" exact="Viral" post="pathogens : Orthomyxoviruses : Influenza viruses: Influenza A virus"/>
 <result pre="Pathology and laboratory medicine : Pathogens : Microbial pathogens :" exact="Viral" post="pathogens : Orthomyxoviruses : Influenza viruses: Influenza A virus"/>
 <result pre=": Biology and life sciences : Organisms : Viruses :" exact="Viral" post="pathogens : Orthomyxoviruses : Influenza viruses: Influenza A virus"/>
 <result pre="Hong Kong, Pokfulam, Hong Kong[2], State Key Laboratory for Emerging" exact="Infectious" post="Diseases and Department of Microbiology, The University of Hong"/>
 <result pre="Kong, Pokfulam, Hong Kong[2], State Key Laboratory for Emerging Infectious" exact="Diseases" post="and Department of Microbiology, The University of Hong Kong,"/>
 <result pre="provided the original author and source are credited.ppat.1008611.pdf Abstract Human" exact="infection" post="with avian influenza A (H5N1) and (H7N9) viruses causes"/>
 <result pre="original author and source are credited.ppat.1008611.pdf Abstract Human infection with" exact="avian influenza" post="A (H5N1) and (H7N9) viruses causes severe respiratory diseases."/>
 <result pre="with avian influenza A (H5N1) and (H7N9) viruses causes severe" exact="respiratory" post="diseases. PB1-F2 protein is a critical virulence factor that"/>
 <result pre="PB1-F2 protein is a critical virulence factor that suppresses early" exact="type I" post="interferon response, but the mechanism of its action in"/>
 <result pre="response by PB1-F2 of H7N9 virus. Author summary Exactly why" exact="avian influenza" post="A (H5N1) and (H7N9) viruses cause severe diseases in"/>
 <result pre="are within the manuscript and its Supporting Information files. Introduction" exact="Avian" post="influenza A (H5N1) and (H7N9) viruses occasionally cross species"/>
 <result pre="viruses occasionally cross species barrier to infect humans, causing severe" exact="respiratory" post="disease and posing pandemic threats. In 1997, human infection"/>
 <result pre="occasionally cross species barrier to infect humans, causing severe respiratory" exact="disease" post="and posing pandemic threats. In 1997, human infection with"/>
 <result pre="severe respiratory disease and posing pandemic threats. In 1997, human" exact="infection" post="with H5N1 virus in Hong Kong caused 6 deaths"/>
 <result pre="caused 6 deaths out of 18 infected individuals presented with" exact="viral pneumonia," post="acute respiratory distress syndrome and multiple organ failure [1,"/>
 <result pre="deaths out of 18 infected individuals presented with viral pneumonia," exact="acute respiratory distress syndrome" post="and multiple organ failure [1, 2]. Since then, H5N1"/>
 <result pre="out of 18 infected individuals presented with viral pneumonia, acute" exact="respiratory" post="distress syndrome and multiple organ failure [1, 2]. Since"/>
 <result pre="18 infected individuals presented with viral pneumonia, acute respiratory distress" exact="syndrome" post="and multiple organ failure [1, 2]. Since then, H5N1"/>
 <result pre="emerged in humans in mainland China, presented with similar severe" exact="disease" post="with 40% case mortality [4, 5]. At least four"/>
 <result pre="studies using ferret model suggested H7N9 transmissibility between ferrets through" exact="respiratory" post="droplets [8]. This is alarming and the pandemic potential"/>
 <result pre="cytokine storm [4, 5], in which proinflammatory cytokines such as" exact="tumor" post="necrosis factor (TNF) α are induced to very high"/>
 <result pre="+1 open reading frame of the PB1 segment of the" exact="viral" post="genome, with a full length of 90 amino acids,"/>
 <result pre="mitochondrial protein that induces apoptosis of immune cells [13]. PB1-F2" exact="deficiency" post="results in attenuation of the virus in mammals, but"/>
 <result pre="importantly, PB1-F2 suppresses innate immunity and this suppression correlates with" exact="viral" post="pathogenicity. PB1-F2 with an S66 residue has been found"/>
 <result pre="Mechanistically, S66 version of PB1-F2 suppresses RIG-I-MAVS signaling and early" exact="type I" post="interferon (IFN) production [17] through dissipation of mitochondrial membrane"/>
 <result pre="from an avian virus, was found to specifically suppress TBK1-mediated" exact="type I" post="IFN production by co-degradation with DDX3X [21]. H5N1 and"/>
 <result pre="as in the 1918 pandemic strain [21]. Whether and how" exact="type I" post="IFN antagonism of PB1-F2 might contribute to high pathogenicity"/>
 <result pre="H7N9 virus. This virus subtype-specific suppression of MAVS aggregation and" exact="type I" post="IFN production by H7N9 PB1-F2 has implications in H7N9"/>
 <result pre="production by H7N9 PB1-F2 has implications in H7N9 pathogenesis and" exact="disease" post="intervention. Results Unique features of H7N9 PB1-F2 protein H7N9"/>
 <result pre="weakly similar residues are indicated by *,: and., respectively. (B)" exact="Protein" post="expression. HEK293T and DF-1 cells in 6-well plates were"/>
 <result pre="μM MG132 for 6 more hours and then subjected to" exact="total" post="protein extraction and Western blot analysis with anti-Flag. α-tubulin"/>
 <result pre="upon treatment of cells with proteasome inhibitor MG132 (Fig 1B," exact="upper" post="panel, lane 2 vs 1). In contrast, H7N9 PB1-F2"/>
 <result pre="H7N9 PB1-F2 was most abundant in HEK293T cells in the" exact="absence of" post="MG132 (Fig 1B, upper panel, lane 5 vs 1"/>
 <result pre="in HEK293T cells in the absence of MG132 (Fig 1B," exact="upper" post="panel, lane 5 vs 1 and 3) and its"/>
 <result pre="expression level of H5N1 PB1-F2 in HEK293T cells in the" exact="absence of" post="MG132 was between those of its counterparts in WSN"/>
 <result pre="those of its counterparts in WSN and H7N9 (Fig 1B," exact="upper" post="panel, lane 3 vs 1 and 5), and it"/>
 <result pre="results were also observed in chicken DF-1 cells (Fig 1B," exact="lower" post="panel). These results might indicate the unique features of"/>
 <result pre="features of H7N9 PB1-F2 in protein expression, abundance, stability and" exact="susceptibility to" post="proteasomal degradation. Aggregation of H7N9 PB1-F2 WSN PB1-F2 has"/>
 <result pre="adopt parallel pairing at residues 55–58 with an energy of" exact="lower" post="than -5.31 PEU, multiple highly probable anti-parallel pairings were"/>
 <result pre="contrast, high-molecular-mass species of H7N9 PB1-F2 were visible in the" exact="absence of" post="MG132 and the potentiating effect of MG132 on them"/>
 <result pre="mitochondrial clusters were further confirmed by Z-stack imaging at various" exact="focal" post="planes through Z-axis spaced by 0.7 μm (S2 Fig)."/>
 <result pre="clusters. Fig 2 Influence of H7N9 PB1-F2 expression on mitochondrial" exact="morphology" post="and function. (A) Mitotracker Red CMXRos staining. HEK293T cells"/>
 <result pre="0.01. *: P &amp;lt; 0.05. n.s.: P &amp;gt; 0.05. (C)" exact="Mitochondrial" post="clustering. Cells with clustered mitochondria colocalized with PB1-F2 as"/>
 <result pre="were calculated by number of cells with clustered mitochondria over" exact="total" post="number of cells. For each experiment, at least 90"/>
 <result pre="total number of cells. For each experiment, at least 90" exact="total" post="cells were counted. The data represent mean values ±"/>
 <result pre="with PB1-F2 were calculated as in (C). Suppression of MAVS-dependent" exact="type I" post="IFN production by H7N9 PB1-F2 Mitochondrial adaptor protein FAF1"/>
 <result pre="Suppression of MAVS-dependent type I IFN production by H7N9 PB1-F2" exact="Mitochondrial" post="adaptor protein FAF1 has recently been found to form"/>
 <result pre="PB1-F2 and H5N1 PB1-F2 have also been shown to suppress" exact="type I" post="IFN production [17, 44]. To shed light on the"/>
 <result pre="and IRF3-5D (S3G Fig) were comparable in the presence and" exact="absence of" post="PB1-F2s. However, MAVS expression was diminished when PB1-F2 was"/>
 <result pre="constructs, 100ng p125-Luc, 10ng pRL-TK and 50ng expression constructs for" exact="type I" post="IFN stimulants including RIG-IN (C), MyD88 (D), MAVS in"/>
 <result pre="H5N1 carrying the S66 pathogenic marker were found to suppress" exact="type I" post="IFN production through MAVS [17–19, 48]. To test if"/>
 <result pre="of PB1-F2 proteins of PR8 and H5N1 with S66 were" exact="lower" post="in Sendai virus-infected cells, but much more pronounced IFN"/>
 <result pre="likely suppressed MAVS through another S66-independent mechanism. H7N9 PB1-F2 suppresses" exact="type I" post="IFN production during influenza A virus infection To monitor"/>
 <result pre="H7N9 PB1-F2 suppresses type I IFN production during influenza A" exact="virus infection" post="To monitor if PB1-F2 has an impact on type"/>
 <result pre="PB1-F2 suppresses type I IFN production during influenza A virus" exact="infection" post="To monitor if PB1-F2 has an impact on type"/>
 <result pre="virus infection To monitor if PB1-F2 has an impact on" exact="type I" post="IFN response during influenza A virus infection, recombinant viruses"/>
 <result pre="an impact on type I IFN response during influenza A" exact="virus infection," post="recombinant viruses H7-2 wild type (WT) and H7-2 ΔF"/>
 <result pre="model cell lines THP-1 and A549 at a multiplicity of" exact="infection" post="(MOI) of 1. IFNβ mRNA expression was less robust"/>
 <result pre="at 12 and 24 hours-post-infection (hpi; Fig 4B). Levels of" exact="viral" post="transcripts (represented by those of segments 4 and 6)"/>
 <result pre="4B), suggesting that H7N9 PB1-F2 specifically suppressed the production of" exact="type I" post="IFNs but not proinflammatory cytokines. The replication of H7-2"/>
 <result pre="reports that PB1-F2 proteins of H9N2, H5N1 and H7N9 promote" exact="viral" post="replication in human lung epithelial cells (i.e. A549) by"/>
 <result pre="H9N2, H5N1 and H7N9 promote viral replication in human lung" exact="epithelial" post="cells (i.e. A549) by preventing HAX-1 from inhibiting viral"/>
 <result pre="lung epithelial cells (i.e. A549) by preventing HAX-1 from inhibiting" exact="viral" post="polymerase subunit PA [14, 15]. However, although enhanced replication"/>
 <result pre="in infected A549 and THP-1 cells. Fig 4 Suppression of" exact="type I" post="IFN response by H7N9 PB1-F2 in cells infected with"/>
 <result pre="n.s.: P &amp;gt; 0.05. (D) WSN PB1-F2 does not suppress" exact="type I" post="IFN response during viral infection. THP-1 cells were infected"/>
 <result pre="WSN PB1-F2 does not suppress type I IFN response during" exact="viral infection." post="THP-1 cells were infected with WSN WT or WSN"/>
 <result pre="3A to 3J). To verify this in the context of" exact="viral infection," post="WSN virus (WSN WT) and its PB1-F2 defective mutant"/>
 <result pre="and WSN ΔF. Levels of IFNβ mRNA, TNFα mRNA and" exact="viral" post="RNA segments were compared (Fig 4D). Unlike H7-2 WT"/>
 <result pre="cells (Fig 4D). Hence, WSN PB1-F2 had no influence on" exact="type I" post="IFN induction during viral infection in THP-1 cells, whereas"/>
 <result pre="PB1-F2 had no influence on type I IFN induction during" exact="viral infection" post="in THP-1 cells, whereas H7N9 PB1-F2 exerted a significant"/>
 <result pre="had no influence on type I IFN induction during viral" exact="infection" post="in THP-1 cells, whereas H7N9 PB1-F2 exerted a significant"/>
 <result pre="strictly regulated by both proteasomal and lysosomal degradation to prevent" exact="uncontrolled" post="signal activation [49]. We monitored MAVS expression levels in"/>
 <result pre="for by the difference in MAVS mRNA levels (Fig 5B)." exact="Viral" post="protein expression as represented by the level of PA"/>
 <result pre="was not detectable at 24 hpi (Fig 5A). The same" exact="infection" post="experiment was performed in THP-1 cells with WSN WT"/>
 <result pre="the level of MAVS protein in the early phase of" exact="infection" post="with H7N9 but not WSN. This finding was compatible"/>
 <result pre="6, 12, and 24 hpi, infected cells were harvested for" exact="total" post="protein extraction, SDS-PAGE and Western blot analysis with anti-MAVS"/>
 <result pre="PB1-F2 (A). PA and GAPDH served as normalization controls for" exact="viral infection" post="and loading. Harvested cells were also subjected to RT-qPCR"/>
 <result pre="(A). PA and GAPDH served as normalization controls for viral" exact="infection" post="and loading. Harvested cells were also subjected to RT-qPCR"/>
 <result pre="100 μg/mL cycloheximide (CHX) was added. Cells were harvested for" exact="total" post="protein extraction at 0, 6, 12 and 24 hours"/>
 <result pre="band intensity of MAVS over GAPDH was plotted in the" exact="lower" post="panel. (F) HEK293T cells were transfected with 0.5 μg"/>
 <result pre="and 2 μg). After 48 hours, cells were harvested for" exact="total" post="protein extraction followed by SDS-PAGE and Western blot analysis"/>
 <result pre="1 μg/mL poly (I:C) for 18 hours before harvested for" exact="total" post="protein extraction followed by SDS-PAGE and Western blot analysis"/>
 <result pre="virus (100 hemagglutinating units/ml) for 18 hours before harvested for" exact="total" post="protein extraction followed by SDS-PAGE and Western blot analysis"/>
 <result pre="5G and 5I). However, upon transfection with poly (I:C) or" exact="infection" post="with Sendai virus, protein expression levels of MAVS were"/>
 <result pre="protein filament on mitochondria, which is required for propagation of" exact="type I" post="IFN response [50–52]. To explore how H7N9 PB1-F2 destabilized"/>
 <result pre="for 6 or 16 hours before cells were harvested for" exact="total" post="protein extraction and SDS-PAGE Western blot analysis against anti-Flag."/>
 <result pre="pEF-Bos-Flag-MAVS WT, E26A, W56R or R64, 65A. After 48 hours," exact="total" post="protein was extracted from the cells and subjected to"/>
 <result pre="band intensity of MAVS over GAPDH was plotted in the" exact="lower" post="panel. Three independent experiments were performed with similar results."/>
 <result pre="Since expression of H7N9 PB1-F2 led to reduction of the" exact="total" post="level of MAVS protein (Fig 5), HEK293T cells were"/>
 <result pre="0.2 μg so that steady-state level of overexpressed MAVS became" exact="stable" post="(Fig 5F). WSN PB1-F2 and H5N1 PB1-F2 were included"/>
 <result pre="was observed (Fig 7C, panels 11–15). Indeed, H7N9 PB1-F2 still" exact="localized" post="to mitochondrial clusters as shown in Fig 2A, but"/>
 <result pre="of CARD domain-dependent aggregation [56, 57]. Instead, TRAF6-MAVS interaction requires" exact="complete" post="MAVS aggregation through CARD-CARD interaction [51, 52]. MAVS interaction"/>
 <result pre="of H7N9 PB1-F2 on TRIM31 binding and polyubiquitination of MAVS" exact="Protein" post="aggregation has an inhibitory effect on proteasomal degradation [59–61]."/>
 <result pre="an inhibitory effect on proteasomal degradation [59–61]. In addition, MAVS" exact="localized" post="to fissioned mitochondria (Fig 7C) might also be prone"/>
 <result pre="how H7N9 PB1-F2 triggers MAVS degradation, ubiquitination assay was performed." exact="General" post="ubiquitination of MAVS was only reduced slightly when H7N9"/>
 <result pre="Our findings highlight the importance of PB1-F2 in pathogenicity of" exact="avian influenza" post="A viruses H7N9 and H5N1. We demonstrated the aggregation-prone"/>
 <result pre="known to bind with phosphotidyethanolamine [79]. Here we showed that" exact="viral" post="protein PB1-F2 of avian influenza virus H7N9 formed protein"/>
 <result pre="phosphotidyethanolamine [79]. Here we showed that viral protein PB1-F2 of" exact="avian influenza" post="virus H7N9 formed protein aggregates on mitochondria, perturbed TRIM31-MAVS"/>
 <result pre="interacts tightly with MAVS, they likely co-aggregate to form a" exact="stable" post="FAF1-MAVS complex. In contrast, no interaction between H7N9 PB1-F2"/>
 <result pre="MAVS was detected (Fig 7B). Instead, H7N9 PB1-F2 aggregated and" exact="localized" post="to distinct sub-compartment of clustered mitochondria (Fig 2A), adjacent"/>
 <result pre="but attached to mitochondria through an unknown factor [79]. Sendai" exact="virus infection" post="enhances MAVS-TRIM31 complex formation [71], suggesting that MAVS aggregation"/>
 <result pre="attached to mitochondria through an unknown factor [79]. Sendai virus" exact="infection" post="enhances MAVS-TRIM31 complex formation [71], suggesting that MAVS aggregation"/>
 <result pre="formed amyloid aggregates on mitochondria leading to alteration of mitochondrial" exact="morphology" post="(Fig 2A), which might pose steric hindrance to aggregation"/>
 <result pre="destabilize MAVS (Fig 5G and 5I). Thus, the two pathogenic" exact="avian influenza" post="viruses share a similar MAVS-destabilizing property. It will be"/>
 <result pre="had no influence on basal activity of MAVS in the" exact="absence of" post="immune stimulation. Plausibly, H7N9 PB1-F2 functions to prevent excessive"/>
 <result pre="PB1-F2 might aggregate more rapidly. In our setting, H7-2 WT" exact="infection" post="at an MOI of 1 strikingly reduced MAVS protein"/>
 <result pre="at 6 hpi (Fig 5A), leading to an inhibition of" exact="type I" post="IFN production at 12 and 24 hpi (Fig 4B)."/>
 <result pre="further as to how H7N9 PB1-F2 aggregates in infected cells." exact="Lethal" post="H5N1 and H7N9 infection arises from cytokine storm [1,"/>
 <result pre="H7N9 PB1-F2 aggregates in infected cells. Lethal H5N1 and H7N9" exact="infection" post="arises from cytokine storm [1, 5]. Here we found"/>
 <result pre="[1, 5]. Here we found that H7N9 PB1-F2 potently suppressed" exact="type I" post="IFN expression but might not affect production of proinflammatory"/>
 <result pre="signaling by H7N9 PB1-F2 might exert a specific effect on" exact="type I" post="IFN production but minimally affect the overall proinflammatory response."/>
 <result pre="of H7N9 infection, with profound proinflammatory cytokine production but attenuated" exact="type I" post="IFN production and signaling [81, 82]. This is also"/>
 <result pre="for construction of candidate attenuated vaccines due to its potent" exact="type I" post="IFN-inducing property [84]. However, severely attenuated replication of the"/>
 <result pre="live attenuated influenza vaccines [86]. Although the elevation of the" exact="type I" post="IFN-inducing activity of the recombinant H7N9 PB1-F2-deficient virus was"/>
 <result pre="PB1-F2 knockout was achieved by using Q5® Site-Directed Mutagenesis Kit." exact="Primary" post="antibodies Commercial primary antibodies used in this study included"/>
 <result pre="achieved by using Q5® Site-Directed Mutagenesis Kit. Primary antibodies Commercial" exact="primary" post="antibodies used in this study included mouse anti-Flag (M2;"/>
 <result pre="rabbit anti-COXIV (3E11; Cell Signaling) and rabbit anti-PA (PA5-32224; Invitrogen)." exact="Mouse" post="monoclonal antibody to PB1-F2 was raised using the custom"/>
 <result pre="10% fetal bovine serum. MDCK cells were maintained in Minimum" exact="Essential" post="Medium with 10% fetal bovine serum. THP-1 cells were"/>
 <result pre="then further propagated twice in Vero-E6 cells to achieve sufficient" exact="viral" post="titer for infection. General protein, RNA and reporter assays"/>
 <result pre="in Vero-E6 cells to achieve sufficient viral titer for infection." exact="General" post="protein, RNA and reporter assays Total protein sample was"/>
 <result pre="viral titer for infection. General protein, RNA and reporter assays" exact="Total" post="protein sample was extracted as follows. Cells were lysed"/>
 <result pre="Dual luciferase reporter assay was performed as previously described [45]." exact="Total" post="RNA samples were either extracted with RNAiso PLUS (Takara)"/>
 <result pre="was performed as previously described [45]. For reverse transcription of" exact="viral" post="RNA, Uni12 primer with sequence 5´-AGCAAAAGCAGG-3´ was used. qPCR"/>
 <result pre="blocked with 5% nonfat dried milk and then incubated with" exact="primary" post="antibody. The blot was probed with secondary antibody conjugated"/>
 <result pre="then incubated with primary antibody. The blot was probed with" exact="secondary" post="antibody conjugated with horseradish peroxidase. Protein aggregate ladder was"/>
 <result pre="blot was probed with secondary antibody conjugated with horseradish peroxidase." exact="Protein" post="aggregate ladder was detected with WesternBright ECL (Advansta). Protein"/>
 <result pre="peroxidase. Protein aggregate ladder was detected with WesternBright ECL (Advansta)." exact="Protein" post="solubility assay Cells were lysed with cold RIPA lysis"/>
 <result pre="A small portion of crude lysate was isolated out for" exact="total" post="protein sample extraction as described. The crude lysate was"/>
 <result pre="was removed by further centrifugation at 21,500×g for 10 min." exact="Protein" post="samples of total protein, RIPA-soluble and RIPA pellet fractions"/>
 <result pre="further centrifugation at 21,500×g for 10 min. Protein samples of" exact="total" post="protein, RIPA-soluble and RIPA pellet fractions were analyzed by"/>
 <result pre="with 3% BSA. After that, the cells were probed with" exact="primary" post="antibody overnight at 4°C. On the next day, cells"/>
 <result pre="with PBS followed by probing with 0.5 μg/mL DAPI and" exact="secondary" post="antibodies with appropriate origin and fluorophore. After three washes"/>
 <result pre="putative cross β sheet structure using PASTA 2.0 (http://protein.bio.unipd.it/pasta2/). Predicted" exact="secondary" post="structure and putative parallel or anti-parallel cross β-pairing were"/>
 <result pre="(TIF) LINK Click here for additional data file. S3 Fig" exact="Protein" post="expression levels of PB1-F2s and the other proteins of"/>
 <result pre="HEK293T cells as described in Fig 3 were subjected to" exact="total" post="protein sample extraction followed by SDS-PAGE and Western blot"/>
 <result pre="sample extraction followed by SDS-PAGE and Western blot analysis. (A)" exact="Protein" post="samples of HEK293T cells transfected with PB1-F2-Flag plasmids and"/>
 <result pre="for expression level of PB1-F2-Flag normalized to GAPDH level. (B)" exact="Protein" post="samples of HEK293T cells transfected with PB1-F2-Flag plasmid and"/>
 <result pre="ChanPK, PeirisM, TsangDN, QueTL, ShortridgeKF, et al.Clinical features and rapid" exact="viral" post="diagnosis of human disease associated with avian influenza A"/>
 <result pre="ShortridgeKF, et al.Clinical features and rapid viral diagnosis of human" exact="disease" post="associated with avian influenza A H5N1 virus. Lancet. 1998;351:"/>
 <result pre="features and rapid viral diagnosis of human disease associated with" exact="avian influenza" post="A H5N1 virus. Lancet. 1998;351: 467–471. 10.1016/s0140-6736(98)01182-99482437 2ToKK, NgKH,"/>
 <result pre="3LaiS, QinY, CowlingBJ, RenX, WardropNA, GilbertM, et al.Global epidemiology of" exact="avian influenza" post="A H5N1 virus infection in humans, 1997–2015: a systematic"/>
 <result pre="WardropNA, GilbertM, et al.Global epidemiology of avian influenza A H5N1" exact="virus infection" post="in humans, 1997–2015: a systematic review of individual case"/>
 <result pre="GilbertM, et al.Global epidemiology of avian influenza A H5N1 virus" exact="infection" post="in humans, 1997–2015: a systematic review of individual case"/>
 <result pre="e108–e118. 10.1016/S1473-3099(16)00153-527211899 4GaoR, CaoB, HuY, FengZ, WangD, HuW, et al.Human" exact="infection" post="with a novel avian-origin influenza A (H7N9) virus.N Engl"/>
 <result pre="7ZhouL, ChenE, BaoC, XiangN, WuJ, WuS, et al.Clusters of human" exact="infection" post="and human-to-human transmission of avian influenza A(H7N9) virus, 2013–2017.Emerging"/>
 <result pre="WuS, et al.Clusters of human infection and human-to-human transmission of" exact="avian influenza" post="A(H7N9) virus, 2013–2017.Emerging Infect Dis.2018; 24: 397–400. 8ImaiM, WatanabeT,"/>
 <result pre="from a human is lethal in some ferrets infected via" exact="respiratory" post="droplets. Cell Host Microbe. 2017;22: 615–626.e618. 10.1016/j.chom.2017.09.00829056430 9KoutsakosM, KedzierskaK,"/>
 <result pre="Microbe. 2017;22: 615–626.e618. 10.1016/j.chom.2017.09.00829056430 9KoutsakosM, KedzierskaK, SubbaraoK. Immune responses to" exact="avian influenza" post="viruses. J Immunol. 2019;202: 382–391. 10.4049/jimmunol.180107030617120 10ZamarinD, OrtigozaMB, PaleseP."/>
 <result pre="10ZamarinD, OrtigozaMB, PaleseP. Influenza A virus PB1-F2 protein contributes to" exact="viral" post="pathogenesis in mice. J Virol. 2006;80: 7976–7983. 10.1128/JVI.00415-0616873254 11ChakrabartiAK,"/>
 <result pre="HeG, CardonaC.J, SongY, XingZ. Critical Role of HAX-1 in promoting" exact="avian influenza" post="virus replication in lung epithelial cells. Mediators Inflamm. 2018;2018:"/>
 <result pre="of HAX-1 in promoting avian influenza virus replication in lung" exact="epithelial" post="cells. Mediators Inflamm. 2018;2018: 12. 15Mazel-SanchezB, Boal-CarvalhoI, SilvaF, DijkmanR,"/>
 <result pre="et al.The influenza virus protein PB1-F2 inhibits the induction of" exact="type I" post="interferon at the level of the MAVS adaptor protein.PLoS"/>
 <result pre="ManicassamyB, PaleseP. Influenza virus protein PB1-F2 inhibits the induction of" exact="type I" post="interferon by binding to MAVS and decreasing mitochondrial membrane"/>
 <result pre="2016;291: 9060–9072. 10.1074/jbc.M115.71053326896002 28RadiganKA, MisharinAV, ChiM, BudingerGS. Modeling human influenza" exact="infection" post="in the laboratory.Infect Drug Resist. 2015;8: 311–320. 10.2147/IDR.S5855126357484 29WalshI,"/>
 <result pre="Acids Res. 2018;46: 4054–4071. 10.1093/nar/gky18629547894 36YamadaH, ChounanR, HigashiY, KuriharaN, KidoH." exact="Mitochondrial" post="targeting sequence of the influenza A virus PB1-F2 protein"/>
 <result pre="RossC, IqbalM, GoodbournS, DigardP, BarclayWS, SheltonH. The cellular localization of" exact="avian influenza" post="virus PB1-F2 protein alters the magnitude of IFN2 promoter"/>
 <result pre="40PootM, ZhangYZ, KramerJA, WellsKS, JonesLJ, HanzelDK, et al.Analysis of mitochondrial" exact="morphology" post="and function with novel fixable fluorescent stains. J Histochem"/>
 <result pre="as a sensitive fluorescent probe.Biol Protoc.2019;9: e3128. 42HuangP, YuT, YoonY." exact="Mitochondrial" post="clustering induced by overexpression of the mitochondrial fusion protein"/>
 <result pre="Antiviral Immunityby Inhibiting MAVS but Is Antagonized by Phosphorylation upon" exact="Viral Infection." post="Cell Host Microbe. 2018;24: 776–790.e775. 10.1016/j.chom.2018.10.00630472208 44LeymarieO, MeyerL, TafforeauL,"/>
 <result pre="SiuKL, LiJ, JinDY. MIP-T3 is a negative regulator of innate" exact="type I" post="IFN response. J Immunol. 2011;187: 6473–6482. 10.4049/jimmunol.110071922079989 46YoneyamaM, KikuchiM,"/>
 <result pre="MagorKE, et al.Molecular imprinting as a signal-activation mechanism of the" exact="viral" post="RNA sensor RIG-I. Mol Cell. 2014;55: 511–523. 10.1016/j.molcel.2014.06.01025018021 54Zamorano"/>
 <result pre="Mol Cell. 2014;55: 511–523. 10.1016/j.molcel.2014.06.01025018021 54Zamorano CuervoN, OssemanQ, GrandvauxN. Virus" exact="infection" post="triggers MAVS polymers of distinct molecular weight.Viruses. 2018;10: 56."/>
 <result pre="ligase TRIM25 and degradation by the proteasome is involved in" exact="type I" post="interferon production after activation of the antiviral RIG-I-like receptors.BMC"/>
 <result pre="10.4049/jimmunol.090164619734229 69JinS, TianS, LuoM, XieW, LiT, DuanT, et al.Tetherin suppresses" exact="type I" post="interferon signaling by targeting MAVS for NDP52-mediated selective autophagic"/>
 <result pre="pro-inflammatory cytokine but an attenuated interferon response in human bronchial" exact="epithelial" post="cells when compared with an epidemiologically-linked chicken H7N9 virus.Virol"/>
 <result pre="JossetL, TchitchekN, ChangJ, BelserJA, SwayneDE, et al.H7N9 and other pathogenic" exact="avian influenza" post="viruses elicit a three-pronged transcriptomic signature that is reminiscent"/>
 <result pre="attenuated virus vaccine provides robust protection to aged mice from" exact="viral" post="challenge. J Virol. 2012;86: 10293–10301. 10.1128/JVI.01131-1222787224 86WangP, ZhengM, LauSY,"/>
 <result pre="protein PACT against influenza A virus mediated via suppression of" exact="viral" post="RNA polymerase. FASEB J. 2018;32: 4380–4393. 10.1096/fj.201701361R29513570"/>
</results>
